Resolution ResAP(2007)1
on the classification of medicines as regards their supply
制作网线(superding Resolution ResAP(2000)1 on the classification of medicines
which are obtainable only on medical prescription)
(Adopted by the Committee of Ministers on 12 April 2007
钢铁是怎样炼成的名言警句
at the 993rd meeting of the Ministers’ Deputies)
The Committee of Ministers, in its composition restricted to the reprentatives of Austria, Belgium, Bulgaria, Cyprus, Finland, France, Germany, Ireland, Italy, Luxembourg, the Netherlands, Norway, Portugal, Slovenia, Spain, Sweden, Switzerland and the United Kingdom, member states of the Partial Agreement in the Social and Public Health Field,
Recalling Resolution (59) 23 of 16 November 1959, on the extension of the activities of the Council of Europe in the social and cultural fields;
Having regard to Resolution (96) 35 of 2 October 1996 revising the above-mentioned Partial Agreement, whereby it revid the structures of the Partial Agreement and resolved to continue, on the basis of revid rules replacing tho t out in Resolution (59) 23, the activities hitherto carried out and developed by virtue of that resolution, the being aimed in particular at:
a. raising the level of health protection of consumers in its widest n, including the making of a constant contribution to harmonising – in the field of products having a direct or indirect impact on the human food chain as well as in the fields of pesticides, pharmaceuticals and cosmetics – legislation, regulations and practices governing, on the one hand, quality, efficiency and safety contr
ols for products, and, on the other hand, the safe u of toxic or noxious products;
b. integrating people with disabilities into the community; defining and contributing to the implementation, at a European level, of a model of coherent policy for people with disabilities, which takes account simultaneously of the principles of full citizenship and independent living; contributing to the elimination of barriers to people’s integration whatever their nature, whether psychological, educational, family-related, cultural, social, professional, financial or architectural;
Having regard to the action carried out for veral years for the purpo of harmonising the legislation of the States members of the Partial Agreement in the public health field and, in particular, in the pharmacy ctor;
Considering further that the lack of uniform legislation on the supply of medicines has created problems in the field of public health and still rais difficulties at international level;
Considering new possibilities and means of access to medicines due to new technologies, namely communication technologies, and the need to ensure patients’ access to safe medicines in safe conditions whilst fighting tendencies to over-medication and inappropriate medication;
Considering the broader accessibility of medicines through new technologies, it is necessary to introduce harmonid provisions and conditions favouring the safe u of prescription and non-prescription medicines; Considering that it is more and more important to move towards greater harmonisation of national legislation as regards the supply of medicines;
Considering, moreover, that it is important that prescriptions contain certain minimum information so that they can be authenticated and to ensure that the medicine prescribed is correctly supplied and properly ud;
Considering that it is also important to harmoni this information, particularly in view of the increa in international travel;
Bearing in mind the results of the comparative study on the requirements to which prescriptions are subject in the member states of this Partial Agreement,
1. Recommends to the governments of the member states of the Partial Agreement in the Social and Public Health Field that they supply information on the national legal classification of medicines as regards their supply on a regular basis;
2. Recommends to the same governments that they apply the general provisions and the classification of active substances depending on the supply conditions of the medicines which contain them, as t out in the appendices;1
3. Recommends to the same governments that they adopt the general provisions t out below, relating to minimum information to be included in prescriptions;
4. Invites the same governments to accept amendments which may be made to the appendices1 to this resolution by the Public Health Committee (Partial Agreement) (CD-P-SP), which shall carry out, either itlf or through subordinate bodies, an annual revision of the appended lists of active substances classified according to the conditions of supply of medicines which contain them in the light of the general provisions t out hereafter and of national information.
General provisions governing the drawing-up and periodical revision of the list of active substances classified according to the conditions of supply of the medicines which contain them
1. The only active substances affected by the recommended provisions are tho contained in medicines for human u.
2. Narcotic drugs are not referred to when they are already covered by special common provisions concerning the rules governing their supply.
3. This resolution does not apply to homeopathic preparations or to other similar non-allopathic, minute-do preparations available on the market in the member states. Sale and supply of the preparations are governed by legal provisions in force in each member state.
4. The lists of active substances classified according to the conditions of supply of the medicines which contain them are drawn up with reference to all the risks, direct or indirect, which they may reprent to human health if they are ud in accordance with the leaflet or not. In particular, the lists of active substances and the conditions of supply of the medicines in which they are contained are drawn up according to:
a.their acute and chronic toxicity;
b. clinical experience in u (adver reactions, precautions for u, interactions, et
c.);
1 In Resolution ResAP(2000)1 on the legal classification of medicines which are obtainable only on
medical prescription preceding Resolution ResAP(2007)1 on the classification of medicines as regards their supply, the Committee of Ministers, in its composition restricted to the reprentatives of the member states of the Partial Agreement in the Social and Public Health Field, delegated to the Public Health Committee (Partial Agreement) (CD-P-SP) the responsibility for carrying out the annual revisions of the lists of active substances and their classification according to the conditions of supply of the medicines which contain them in the appendices of the above-mentioned resolutions. Thus, the appendices I, II and III in their current edition are not subject to adoption by the Committee of Ministers in its composition restricted to the reprentatives of the member states of the Partial Agreement in the Social and Public Health Field.
Appendix I: Alphabetical list of active substances and their classification according to the conditions of supply of the prescription medicines which contain them.
Appendix II: Anatomical Therapeutic Chemical (ATC) Classification of prescription medicines containing the active substances in the alphabetical list in Appendix I.
Appendix III: Supply conditions of medicines exempt from the obligation to obtain a prescription containing certain active substances listed in Appendices I and II.
水浒传的好词好句
风雨张居正
c. their intended actions and therapeutic indications.
篮球防守规则For the purpo of this resolution, salts, esters and salts of esters are subject to the same classification as the active substances from which they are derived unless otherwi specified in the lists.
In cas where veral substances are prent in a medicine, the classification will take account of the phenomena of synergy or of antagonism.
5. A medicine should be supplied on a medical prescription when one or more of the following conditions apply:
a. it contains an active substance not previously ud for medical purpos. In such a ca, a revision of any restrictions should be carried out within a period of not less than three years from the first date of marketing authorisation in one of the member states of the Partial Agreement;
b. it is ud parenterally;2
c. the medicine contains one or more active substances classified in List I or II3 in Appendix I, to which the following criteria apply:
i. List I
The supply of a medicine containing one of the substances in this list may only be repeated if the prescriber so specifies on the prescription.
ii. List II
The supply of a medicine containing one of the substances in this list may be repeated without the prescriber having so specified, provided that he did not explicitly forbid such repetition and that the amount supplied at renewals (and their frequency) be consistent with medical and pharmaceutical data (such as the prescribed daily do, the duration of treatment, the degree of medical supervision required by the condition, etc.).
iii. Exemptions from Lists I and II
– For certain substances, exemptions from the “prescription only” requirement may appear in Lists I and II and their conditions of supply are indicated in Appendix III:1
- in respect of a low dosage or concentration of the active substances and/or therapeutic indications of medicines in which they are contained;
- according to the route of administration and the composition of the medicine;
- according to the total content of the medicine per container.
– List of active substances classified according to the conditions of supply of the medicines which contain them, when supplied without prescription (over-the-counter (OTC) medicines) and their conditions of supply (Appendix III1).
See “Medicines not subject to prescription (OTC medicines)” below.
General criteria for classification in the lists
1.List I
2 Parenteral u refers to, in particular, epidural, extra-amniotic, intra-amniotic, intra-arterial, intra-articular, intrabursal, intracardiac, intracavernous, intracervical, intracisternal, intracoronary, intracutaneous, intradiscal, intralymphatic, intramuscular, intra-ocular, intraperitoneal, intrapleural, intraspinal, intrasternal, intrathecal, intratracheal, intravenous, peri-articular, perineural, subconjunctival and subcutaneous u.
3 The differentiation in the two lists applies only to the countries which divide prescription medicines into two categories bad on whether or not the supply may be repeated.
a.Active substances of medicines indicated for conditions calling for short-term treatment and/or for which continuous medical supervision is necessary, either becau of potential undesirable effects or to check the efficacy of treatment;
b.Active substances of medicines administered for diagnostic purpos;
c.Active substances with a new pharmacological mechanism of action.
2. List II
Active substances of medicines indicated for conditions for which the patient may continue the regular or intermittent treatment without new medical advice, and for which well-known undesirable effects do not call for frequent clinical examination.
3. List of OTC medicines
See below.
Medicines not subject to prescription (OTC medicines)
Active substances of medicines which are classified as not subject to prescription according to the criteria listed in item 4 of the General Provisions above will be classified in the list “Medicines not subject to prescription (OTC medicines)”.
For the purpo of this resolution, OTC medicines are understood as having a valid marketing authorisation issued by a competent authority.
It is possible that active substances which are contained in OTC medicines can exist in medicines of the same ATC (Anatomical Therapeutic Chemical Classification), but subject to prescription, becau of particular conditions of u of the medicines in question.
General provisions relating to minimum information to be included in prescriptions
1. The information given in prescriptions should be clear and legible.
2. Prescriptions should include the following minimum information:
- name, address and, where appropriate, identification number of the prescriber;
- professional qualification of the prescriber;
- date of the prescription;
- hand-written or electronic signature of the prescriber as t-out in specific national or European
legislation;
- first and cond name of the patient;
过度负债
- age of the patient and, where necessary, details of height and weight;
- name, dosage and pharmaceutical form of the medicine;
- amount to be supplied;
蚝油菜心的做法- instructions for u stating, for example, dosage and length of treatment.
Preamble to the list of active substances classified according to the conditions of supply of medicines which contain them
王尔德童话读后感
1. The governments are free to apply stricter rules as regards the recommended classification of medicines in any given ca.
2. Active substances are classified on the basis of the World Health Organisation (WHO) ATC codes of the medicines which contain them, if available.
3. Active substances not included in the lists have either not been studied or a medicine containing them has not been authorid in at least three member states.
4. Nomenclature
Wherever possible, the nomenclature ud for an active substance is that of the International Non-Proprietary Names (INN) of the WHO.
5. Revisions
Annual revisions will deal with:
– classification of new active substances entering into the composition of medicines newly authorid in the states members of the Partial Agreement;
– classification of substances referred to in item 2 of this preamble;
– proposals for adding or deleting active substances;
– proposals for adding or deleting derogations;
– proposals for modifying exemption conditions or the classification in the list of OTC medicines.
Proposals for revision of classification will be submitted according to the annual ssions of the entrusted bodies of the Council of Europe to be adopted and published after their last annual ssion. In urgent cas, proposals for revision may be submitted at any time.
6. Date of adoption
The published list will indicate in each ca the year of adoption by the Public Health Committee (Partial Agreement) (CD-P-SP) or the subordinate bodies it may entrust.